Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5414/CP203817 http://scihub22266oqcxt.onion/10.5414/CP203817 33191908!ä!33191908 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Clin+Pharmacol+Ther 2021 ; 59 (3): 175-181 Nephropedia Template TP {{tp|p=33191908|t=2021. Drug therapy strategies for COVID-19 infection during pregnancy |pdf=|usr=}}{{33191908}} gab.com Text Drug therapy strategies for COVID-19 infection during pregnancy JO: Int J Clin Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33191908 #FOAvip Acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has spread rapidly in numerous countries and caused a massive number of deaths. Interferon-alpha (IFN-alpha), lopinavir/ritonavir, chloroquine phosphate, arbidol, ribavirin, remdesivir, and dexamethasone are the therapeutic drugs recommended for treating 2019-nCoV disease (COVID-19 disease). Due to the particularity of immune function, pregnant women seem to be more susceptible to the virus. We searched the literature to find effective and safe drugs for patients with COVID-19 during pregnancy and to provide drug therapy strategies for medical staff. According to the current literature we reviewed, we suggest that IFN-alpha and arbidol can be retained in the treatment regimen for pregnant women and that to reduce maternal mortality, appropriate doses of dexamethasone can be given to those who are predicted to have low premature survival and to receive mechanical ventilation or oxygen. However, the use of dexamethasone in the 1(st) trimester and after 37 weeks of gestation should be avoided. Twit Text FOAVip Drug therapy strategies for COVID-19 infection during pregnancy ????Int J Clin Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33191908 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33191908 #FOAvip English Wikipedia <ref>{{Cite pmid|33191908}}</ref> Drug therapy strategies for COVID-19 infection during pregnancy #MMPMID33191908 Wang H; Gao Y; Wu B Int J Clin Pharmacol Ther 2021[Mar]; 59 (3): 175-181 PMID33191908show ga Acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has spread rapidly in numerous countries and caused a massive number of deaths. Interferon-alpha (IFN-alpha), lopinavir/ritonavir, chloroquine phosphate, arbidol, ribavirin, remdesivir, and dexamethasone are the therapeutic drugs recommended for treating 2019-nCoV disease (COVID-19 disease). Due to the particularity of immune function, pregnant women seem to be more susceptible to the virus. We searched the literature to find effective and safe drugs for patients with COVID-19 during pregnancy and to provide drug therapy strategies for medical staff. According to the current literature we reviewed, we suggest that IFN-alpha and arbidol can be retained in the treatment regimen for pregnant women and that to reduce maternal mortality, appropriate doses of dexamethasone can be given to those who are predicted to have low premature survival and to receive mechanical ventilation or oxygen. However, the use of dexamethasone in the 1(st) trimester and after 37 weeks of gestation should be avoided. |*COVID-19[MESH] |*Coronavirus Infections/drug therapy[MESH] |*Pregnancy Complications, Infectious/drug therapy[MESH] |Antiviral Agents/adverse effects[MESH] |Drug Combinations[MESH] |Female[MESH] |Humans[MESH] |Pregnancy[MESH]Drug therapy strategies for COVID-19 infection during pregnancy (epmc).pdf DeepDyve Pubget Overpricing